Pharma Co. May Have Accelerated FDA Approval in 2024
Source: Edward White  (12/20/23)
TRACON Pharmaceuticals Inc. provided an update on enrollment progress for their ongoing Phase 2 ENVASARC clinical trial testing the drug envafolimab to treat sarcoma, reported H.C. Wainwright & Co. More >

'Just Silver' Royalty Co. Looks To Shake Up Sector
Source: Streetwise Reports  (12/19/23)
Silver Crown Royalty Company says it's simplifying the process for investors to gain exposure to royalties and streaming. Read to see what other public companies are aligned with Silver Crown's business and what makes this soon-to-be public company different. More >

Canadian Co. Represents an Ideal Leverage Play on the Price of Gold
Source: Michael Ballanger  (12/19/23)
Michael Ballanger of GGM Advisory Inc. shares why he believes Getchell Gold is a stock worth watching. More >

Lithium Co. Will Be a Substantial Outperformer
Source: Michael Ballanger  (12/19/23)
Michael Ballanger of GGM Advisory Inc. shares a quick note about why he has faith in Volt Lithium Corp. More >

Bioscience Co. Expands Collaboration
Source: Dr. Jonathan Aschoff  (12/19/23)
This bioscience company's price target implies 680% upside, according to a Roth MKM report. More >

Energy Co. Increases Holdings in JV in South Africa
Source: Stephane Foucaud  (12/18/23)
Recently, Chariot Ltd. announced it had acquired increased holdings in South African joint venture, noted Auctus Advisors. More >

Promising Biotech Selling Way Under Cash Value
Source: Ron Struthers  (12/18/23)
Nkarta is using CRISPR technology for cell therapies for leukemia. The FDA just approved a similar cell therapy treatment for Vertex using the same CRISPR technology. Nkarta is trading well below cash value and has a significant short position sinking underwater. More >

Economic Five-Alarm
Source: Michael Ballanger  (12/18/23)
Michael Ballanger of GGM Advisory Inc. shares his thoughts on the current state of the stock markets as well as a few stocks he believes are worth looking into. More >

Fiji-Based Gold Project Reveals Bonanza-Grade Find
Source: Streetwise Reports  (12/15/23)
Lion One has released assay results from its Tuvatu alkaline gold project in Fiji, revealing discoveries of 1,986.23 g/t of gold. Read on to see why analysts like this company's stock. More >

Near Term is Catalyst Rich for B.C. Uranium Explorer
Source: Siddharth Rajeev  (12/15/23)
Through upcoming drill programs, this company and its partners are "growing mergers and acquisitions prospects in the junior uranium space," noted a Fundamental Research Corp. report. More >

Gold Co. Identifies Porphyry Target at Project in B.C.
Source: Mike Kozak  (12/15/23)
Early drill data show the presence of gold mineralization at this explorer's second asset, noted a Cantor Fitzgerald research report. More >

Gold Exploration Company Reveals Exciting Assay Results
Source: Streetwise Reports  (12/15/23)
Collective Mining Ltd. has released the assay results from the Apollo system. Read on to see why one newsletter writer likes this stock. More >

Drilling Confirms Porphyry Potential at BC Project
Source: Taylor Combaluzier  (12/15/23)
Recently, Seabridge Gold announced positive results from its Snip North target at the Iskut project in British Columbia's Golden Triangle, noted a Red Cloud research note. More >

Texas Biotech Advances Lead Candidate in Resistant AML
Source: Dr. Jonathan Aschoff  (12/14/23)
Recently, Texas-based biotech Bio-Path Holdings Inc. announced it had completed the first safety cohort of a Phase 1/1b trial evaluating the developmental drug BP1002 in acute myeloid leukemia (AML). Read on to see what one Roth analyst has to say about the company's stock. More >

Mining Co. Finds Large, High-Grade Copper and Nickel Deposits
Source: Streetwise Reports  (12/13/23)
Stillwater Critical Minerals has announced that it has found a new system of mineralization on its Stillwater West property. Read on the see why analysts like this company's stock. More >

Analysts Predict a Golden New Year
Source: Streetwise Reports  (12/13/23)
According to analysts, the gold market looks ready to hit record prices again in 2024. Read on to see which companies seem ready for the new gold market. More >

Smart Home Product Co. Renews Licensing Agreement
Source: Streetwise Reports  (12/13/23)
This U.S.-based firm continues driving demand for its plug and play electrification tech platform. Find out why experts are bullish on both. More >

Another Exploration Success for Midland
Source: Adrian Day  (12/13/23)
Global Analyst Adrian Day reviews news from three of the companies on his list and answers some reader questions. More >

Ontario Gold Miner Hits High Grade at Eagle River Mine
Source: Ryan Walker  (12/13/23)
While Wesdome Gold Mines announced high-grade drill results, Echelon analyst Ryan Walker still rates it as a Hold. Read on to see why. More >

Copper-Gold Co. Plans 2024 Drill Program
Source: Barry Dawes  (12/13/23)
Barry Dawes of Martin Place Securities shares his thoughts on Tolu Minerals and its upcoming plans for 2024. More >

A Perfect Storm for Commodities
  (12/12/23)
Streetwise sat down with Rick Mills of Ahead of the Herd to go over why he sees a perfect storm forming for commodities and what three stocks have him excited in the new year. More >

Mining Co. Resumes Exploration on High-Grade Gold Property
Source: Streetwise Reports  (12/12/23)
McFarlane Lake Mining has announced that it has begun drilling on its highly mineralized High Lake Project. Read on to see why analysts like this company as gold is breaking out. More >

Mortgage Lender Offering Innovative Solutions as Housing Market Stagnates
Source: Streetwise Reports  (12/12/23)
Beeline Loans Inc. has opened up access to potential homebuyers as the traditional market slows. Read on to see what experts are saying about the housing market. More >

2023, The Dawn of the Silver Boom
Source: Chen Lin  (12/12/23)
Chen Lin shares his silver outlook as well as two stocks he believes are worth looking into. More >

Biotech Seeks Approval of Synthetic Blood Vessel Graft
Source: Vernon Bernardino  (12/12/23)
Humacyte Inc. announced the submission of a Biologics License Application (BLA) to the FDA seeking approval for its lead product candidate Human Acellular Vessel (HAV), noted H.C. Wainwright & Co. Analyst Vernon Bernardino. More >